Upward momentum of pharmaceutical firms shares likely to continue in April
Market analysts say that with increasing optimism on the possible commercialization of new drugs, combined with a foreign investors' buying spree, the index of pharmaceutical firms rose 3.07 percent in February, albeit a fall of 3.6 percent in the Korea Composite Stock Price Index (Kospi)...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
